NCT05620901View on ClinicalTrials.gov

DEXTENZA in Pediatric Patients Following Retinal Surgery or Laser Treatment Under Anesthesia

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

February 11, 2025

Study Completion Date

February 24, 2025

Conditions
VitreoretinopathyCoats' DiseaseExudative RetinopathyLattice DegenerationRetinal HoleSickler's SyndromeRetinal Detachment RhegmatogenousRetinal Detachment ExudativeRetinal Detachment Traction
Interventions
DRUG

Dextenza 0.4Mg Ophthalmic Insert

DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use

DRUG

Pred Forte

To treat perioperative ocular inflammation and pain;

Trial Locations (1)

27710

Duke Eye Center, Durham

All Listed Sponsors
lead

Lejla Vajzovic, MD, FASRS

OTHER